ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAY— 510(k) K031038

Substantially Equivalent

Bayer Healthcare, LLC

FDA 510(k) clearance K031038 for ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAY, Substantially Equivalent on 2003-06-23. Applicant: Bayer Healthcare, LLC.

Clearance details

Applicant: Bayer Healthcare, LLC
Product code: Code NBC
Advisory panel: Clinical Chemistry
Date received: 2003-04-01
Decision date: 2003-06-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.